Pasithea warrants expire Sept 17, 2026; will cease trading and be delisted

Pasithea Therapeutics Corp.

Warrants (KTTAW) expire on September 17, 2026; unexercised warrants become worthless.
Warrants will stop trading on Nasdaq; Form 25 will be filed to delist and deregister them.
Common stock (KTTA) continues to trade on Nasdaq; no change to common listing.
Expiration per terms of Warrant Agency Agreement with VStock Transfer, LLC; no extension noted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.